Late-Breaking Session
Late Breaking Session 1: AI-Empowered Decision Making in Drug /Device Development: Benefit-Risk and Mitigation
Applied
6 Panelists
University of North Carolina-Chapel Hill
US Food and Drug Administration
UC Berkeley
Genentech/Roche
Boehringer Ingelheim Pharma GmbH & Co. KG
US Food & Drug Administration